Potential

Zacks Small Cap Research – SDA: SunCar Technology Group’s Growth Potential Supports Price Target of $20.00. – Go Health Pro

by

By Thomas Kerr, CFA NASDAQ:SDA READ THE FULL SDA RESEARCH REPORT Company Announces New Chief Strategy Officer On January 13, 2025, the SunCar (NASDAQ:SDA) announced that Breaux Walker was appointed Chief Strategy Officer. Mr. Walker will oversee the company’s capital markets strategy, investments, international financing, and investor relations. Mr. Walker has over 25 years of … Read more

AI potential meets ROI pragmatism: 3 crucial questions every CIO should ask – Go Health Pro

by
AI potential meets ROI pragmatism: 3 crucial questions every CIO should ask – Go Health Pro

If you had to name 2023’s single-most impactful and disruptive technology, you’d need just two letters: AI. With the release of OpenAI’s ChatGPT in November 2022, we watched a tsunami of AI news and noise throughout the year. And there’s no sign of things slowing down. Even for technology insiders, the rapid pace of generative … Read more

Zacks Small Cap Research – CTSO: CytoSorbents Announces Rights Offering Which has the Potential to Substantially Increase Available Liquidity – Go Health Pro

by

By Thomas Kerr, CFA NASDAQ:CTSO READ THE FULL CTSO RESEARCH REPORT On December 9, 2024, CytoSorbents (NASDAQ:CTSO) announced a shareholder friendly anticipated Rights Offering which is expected to substantially increase its liquidity position. Investors who own or have bought CTSO stock by the close of trading on Friday, December 13, 2024 will be considered stockholders … Read more

More Defeat Devices and Potential Car Recalls – Go Health Pro

by
More Defeat Devices and Potential Car Recalls – Go Health Pro

Nearly a decade after Volkswagen’s “dieselgate” scandal rocked the automotive industry, a new wave of scrutiny is sweeping across multiple car manufacturers. The UK government’s Department for Transport (DfT) has launched an investigation into “defeat devices” suspected of hiding the true emissions of 47 car models from 11 manufacturers. As concerns mount, UK drivers could … Read more

Zacks Small Cap Research – MGRM: Monogram’s Potential for Profitable Long-Term Growth Supports Price Target of $6.00. – Go Health Pro

by

By Thomas Kerr, CFA NASDAQ:MGRM READ THE FULL MGRM RESEARCH REPORT Monogram (NASDAQ:MGRM) reported 3rd quarter 2024 financial results on November 14th which were largely in line with expectations. Research and development expenses for the quarter ending September 30, 2024 were $2.2 million compared to $2.7 million in the prior year period. The R&D decrease … Read more

x